Lars Olaison

5.7k total citations
60 papers, 3.0k citations indexed

About

Lars Olaison is a scholar working on Epidemiology, Infectious Diseases and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Lars Olaison has authored 60 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Epidemiology, 35 papers in Infectious Diseases and 30 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Lars Olaison's work include Infective Endocarditis Diagnosis and Management (55 papers), Antimicrobial Resistance in Staphylococcus (33 papers) and Streptococcal Infections and Treatments (29 papers). Lars Olaison is often cited by papers focused on Infective Endocarditis Diagnosis and Management (55 papers), Antimicrobial Resistance in Staphylococcus (33 papers) and Streptococcal Infections and Treatments (29 papers). Lars Olaison collaborates with scholars based in Sweden, United States and Spain. Lars Olaison's co-authors include Harriet Hogevik, Rune Andersson, Kjell Alestig, Bruno Hoen, José M. Miró, Elías Abrutyn, Vance G. Fowler, Susannah Eykyn, Christopher H. Cabell and Magnus Rasmussen and has published in prestigious journals such as Clinical Infectious Diseases, Scientific Reports and The American Journal of Medicine.

In The Last Decade

Lars Olaison

60 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lars Olaison Sweden 31 2.6k 1.6k 1.3k 866 793 60 3.0k
Nathan W. Mick United States 7 2.6k 1.0× 1.4k 0.9× 1.2k 0.9× 856 1.0× 729 0.9× 13 3.0k
Jingxiao Li China 3 2.5k 1.0× 1.5k 0.9× 1.2k 0.9× 847 1.0× 720 0.9× 7 2.9k
Edyta Płońska‐Gościniak Poland 10 3.1k 1.2× 1.3k 0.8× 1.1k 0.8× 1.6k 1.8× 1.3k 1.6× 48 3.7k
Ulrika Snygg‐Martin Sweden 13 3.6k 1.4× 1.5k 1.0× 1.3k 0.9× 1.7k 2.0× 1.5k 1.9× 25 4.1k
Pilar Tornos Mas Spain 10 3.5k 1.3× 1.3k 0.9× 1.1k 0.8× 2.0k 2.3× 1.5k 1.9× 17 4.1k
Catherine Chirouze France 18 1.5k 0.6× 987 0.6× 758 0.6× 359 0.4× 712 0.9× 34 2.1k
Christine Selton‐Suty France 34 2.6k 1.0× 1.5k 1.0× 1.3k 1.0× 1.7k 1.9× 995 1.3× 171 4.1k
José M. Miró Spain 33 5.3k 2.0× 3.1k 2.0× 2.1k 1.5× 2.1k 2.4× 1.8k 2.3× 84 6.3k
Thanh Doco‐Lecompte France 15 1.4k 0.5× 970 0.6× 640 0.5× 450 0.5× 386 0.5× 44 1.7k
Holenarasipur R. Vikram United States 28 1.6k 0.6× 1.2k 0.8× 419 0.3× 457 0.5× 734 0.9× 111 2.6k

Countries citing papers authored by Lars Olaison

Since Specialization
Citations

This map shows the geographic impact of Lars Olaison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Olaison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Olaison more than expected).

Fields of papers citing papers by Lars Olaison

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars Olaison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Olaison. The network helps show where Lars Olaison may publish in the future.

Co-authorship network of co-authors of Lars Olaison

This figure shows the co-authorship network connecting the top 25 collaborators of Lars Olaison. A scholar is included among the top collaborators of Lars Olaison based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars Olaison. Lars Olaison is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lund, Bodil, Anders Ternhag, Bengt Götrick, et al.. (2023). Oral streptococcal infective endocarditis among individuals at high risk following dental treatment: a nested case-crossover and case-control study. EClinicalMedicine. 63. 102184–102184. 1 indexed citations
2.
Lund, Bodil, Anders Ternhag, Bengt Götrick, et al.. (2022). Infective Endocarditis Among High-risk Individuals Before and After the Cessation of Antibiotic Prophylaxis in Dentistry: A National Cohort Study. Clinical Infectious Diseases. 75(7). 1171–1178. 8 indexed citations
3.
Rasmussen, Magnus, et al.. (2021). Comparing right- and left sided injection-drug related infective endocarditis. Scientific Reports. 11(1). 1177–1177. 14 indexed citations
4.
Lund, Bodil, Anders Ternhag, Bengt Götrick, et al.. (2020). Incidence of infective endocarditis caused by viridans group streptococci in Sweden – effect of cessation of antibiotic prophylaxis in dentistry for risk individuals. Journal of Oral Microbiology. 12(1). 1768342–1768342. 13 indexed citations
5.
Rasmussen, Magnus, et al.. (2020). Endocarditis due to Staphylococcus lugdunensis—a retrospective national registry–based study. European Journal of Clinical Microbiology & Infectious Diseases. 40(5). 1103–1106. 20 indexed citations
6.
Bläckberg, Anna, Bo Nilson, Volkan Özenci, Lars Olaison, & Magnus Rasmussen. (2018). Infective endocarditis due to Streptococcus dysgalactiae: clinical presentation and microbiological features. European Journal of Clinical Microbiology & Infectious Diseases. 37(12). 2261–2272. 14 indexed citations
7.
Rasmussen, Magnus, et al.. (2014). Comparison of species identification of endocarditis associated viridans streptococci using rnpB genotyping and 2 MALDI-TOF systems. Diagnostic Microbiology and Infectious Disease. 81(4). 240–245. 45 indexed citations
8.
Chirouze, Catherine, Eugene Athan, François Alla, et al.. (2013). Enterococcal endocarditis in the beginning of the 21st century: analysis from the International Collaboration on Endocarditis-Prospective Cohort Study. Clinical Microbiology and Infection. 19(12). 1140–1147. 110 indexed citations
9.
Bjurman, Christian, Ulrika Snygg‐Martin, Lars Olaison, Michael Fu, & Ola Hammarsten. (2012). Cystatin C in a composite risk score for mortality in patients with infective endocarditis: a cohort study. BMJ Open. 2(4). e000856–e000856. 7 indexed citations
10.
Fagman, Erika, Sossio Perrotta, Odd Bech‐Hanssen, et al.. (2012). ECG-gated computed tomography: a new role for patients with suspected aortic prosthetic valve endocarditis. European Radiology. 22(11). 2407–2414. 117 indexed citations
11.
Snygg‐Martin, Ulrika, Rasmus V. Rasmussen, Christian Hassager, et al.. (2011). The relationship between cerebrovascular complications and previously established use of antiplatelet therapy in left-sided infective endocarditis. Scandinavian Journal of Infectious Diseases. 43(11-12). 899–904. 15 indexed citations
12.
Werner, M., et al.. (2008). A 10-year survey of blood culture negative endocarditis in Sweden: Aminoglycoside therapy is important for survival. Scandinavian Journal of Infectious Diseases. 40(4). 279–285. 18 indexed citations
13.
Snygg‐Martin, Ulrika, Lars Gustafsson, Lars Rosengren, et al.. (2008). Cerebrovascular Complications in Patients with Left‐Sided Infective Endocarditis Are Common: A Prospective Study Using Magnetic Resonance Imaging and Neurochemical Brain Damage Markers. Clinical Infectious Diseases. 47(1). 23–30. 211 indexed citations
14.
Lalani, Tahaniyat, Zeina A. Kanafani, Vivian H. Chu, et al.. (2006). Prosthetic valve endocarditis due to coagulase-negative staphylococci: findings from the International Collaboration on Endocarditis Merged Database. European Journal of Clinical Microbiology & Infectious Diseases. 25(6). 365–368. 52 indexed citations
15.
Anderson, Deverick J., Lars Olaison, Jay R. McDonald, et al.. (2005). Enterococcal prosthetic valve infective endocarditis: report of 45 episodes from the International Collaboration on Endocarditis-merged database. European Journal of Clinical Microbiology & Infectious Diseases. 24(10). 665–670. 40 indexed citations
16.
Cabell, Christopher H., Elías Abrutyn, Vance G. Fowler, et al.. (2005). Use of surgery in patients with native valve infective endocarditis: Results from the International Collaboration on Endocarditis Merged Database. American Heart Journal. 150(5). 1092–1098. 95 indexed citations
17.
Miró, José M., Ignasi Anguera, Christopher H. Cabell, et al.. (2005). Staphylococcus aureus Native Valve Infective Endocarditis: Report of 566 Episodes from the International Collaboration on Endocarditis Merged Database. Clinical Infectious Diseases. 41(4). 507–514. 234 indexed citations
18.
Chirouze, Catherine, C. H. Cabell, Vance G. Fowler, et al.. (2004). Prognostic Factors in 61 Cases of Staphylococcus aureus Prosthetic Valve Infective Endocarditis from the International Collaboration on Endocarditis Merged Database. Clinical Infectious Diseases. 38(9). 1323–1327. 92 indexed citations
19.
Hogevik, Harriet, Lars Olaison, Rune Andersson, Johan Lindberg, & Kjell Alestig. (1995). Epidemiologic Aspects of Infective Endocarditis in an Urban Population: A 5-Year Prospective Study. Medicine. 74(6). 324–339. 248 indexed citations
20.
Olaison, Lars & Kjell Alestig. (1990). A prospective study of neutropenia induced by high doses of β-lactam antibiotics. Journal of Antimicrobial Chemotherapy. 25(3). 449–453. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026